HL
Insider selling
Helen Louise Collins sold $192K of ELVN stock
Helen Louise Collins, Chief Medical Officer of Enliven Therapeutics, Inc. (ELVN), sold 5,000 shares of ELVN stock worth $192K, per an SEC Form 4 filed Oct 21, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 19, 2026, 2 days before it was made public.
ELVN has moved +12.9% since the trade date, from $38.70 to $43.69 (Oct 27, 2026 close).
- Traded
- Oct 19, 2026
- Disclosed
- Oct 21, 2026
- Filing delay
- 2 days
- Price since
- +12.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More ELVN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.